In the 100th episode, editor John Hughman and the companies team talk about the bubbling drug discovery pipeline and the ongoing troubles of Europe's banking industry
In the 100th episode, editor John Hughman and the companies team talk about the bubbling drug discovery pipeline and the ongoing troubles of Europe's banking industry